Source:http://linkedlifedata.com/resource/pubmed/id/21642377
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-7-15
|
pubmed:abstractText |
Sporadic primary hyperparathyroidism (PHPT), one of the most common endocrine disorders, is characterized by hypercalcemia and elevated PTH levels. The majority of cases are caused by a benign parathyroid adenoma, but somatic or de novo germ-line mutations that lead to adenoma formation have only been identified in few glands. GCMB is a parathyroid-specific transcription factor, which causes hypoparathyroidism when inactivated on both parental alleles or when a dominant-negative, heterozygous mutation is present. It is overexpressed in some parathyroid adenomas, and we therefore tested the hypothesis that GCMB mutations can be a cause of parathyroid adenomas. Nucleotide sequence analysis was performed on all coding exons and exon-intron borders of GCMB in 30 sporadic parathyroid adenomas and we identified several known polymorphisms that were either heterozygous or homozygous. In addition, one of the 30 investigated glands revealed a novel heterozygous missense mutation, c.1144G>A, which introduced methionine at position 382 for valine (V382M), a conserved amino acid residue. Western blot analysis using mutant GCMB (GCMB-V382M) from lysates of transiently transfected DF-1 fibroblasts, luciferase assays using extracts from these cells, and electrophoretic mobility assays failed to reveal differences between wild-type and mutant GCMB in expression level, transactivational capacity, and DNA-binding ability. Furthermore, pulse-chase experiments demonstrated no difference in half-life of wild-type and mutant protein. We conclude that mutations in the transcription factor GCMB do not seem to play a major role in the pathogenesis of PHPT.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1479-6805
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
210
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
165-71
|
pubmed:meshHeading |
pubmed-meshheading:21642377-Adenoma,
pubmed-meshheading:21642377-DNA Mutational Analysis,
pubmed-meshheading:21642377-Germ-Line Mutation,
pubmed-meshheading:21642377-Humans,
pubmed-meshheading:21642377-Hyperparathyroidism, Primary,
pubmed-meshheading:21642377-Nuclear Proteins,
pubmed-meshheading:21642377-Parathyroid Glands,
pubmed-meshheading:21642377-Parathyroid Neoplasms,
pubmed-meshheading:21642377-Polymorphism, Genetic,
pubmed-meshheading:21642377-Transcription Factors
|
pubmed:year |
2011
|
pubmed:articleTitle |
Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism.
|
pubmed:affiliation |
Endocrine Unit Pediatric Nephrology Unit, Massachusetts General Hospital and Harvard Medical School, Thier 1051, 55 Fruit Street, Boston, Massachusetts 02114, USA. mmannstadt@partners.org
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|